Catawba Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | $572K | Hold |
11,356
| – | – | 0.13% | 123 |
|
|
2018
Q1 | $555K | Buy |
11,356
+648
| +6% | +$31.7K | 0.13% | 124 |
|
|
2017
Q4 | $475K | Sell |
10,708
-5,740
| -35% | -$255K | 0.11% | 137 |
|
|
2017
Q3 | $835K | Buy |
16,448
+250
| +2% | +$12.7K | 0.19% | 103 |
|
|
2017
Q2 | $873K | Buy |
16,198
+1,280
| +9% | +$69K | 0.2% | 106 |
|
|
2017
Q1 | $786K | Sell |
14,918
-398
| -3% | -$21K | 0.17% | 121 |
|
|
2016
Q4 | $737K | Sell |
15,316
-580
| -4% | -$27.9K | 0.17% | 125 |
|
|
2016
Q3 | $857K | Buy |
15,896
+704
| +5% | +$38K | 0.2% | 110 |
|
|
2016
Q2 | $823K | Hold |
15,192
| – | – | 0.2% | 111 |
|
|
2016
Q1 | $770K | Sell |
15,192
-2,140
| -12% | -$108K | 0.2% | 109 |
|
|
2015
Q4 | $874K | Sell |
17,332
-1,512
| -8% | -$76.2K | 0.24% | 99 |
|
|
2015
Q3 | $906K | Buy |
18,844
+456
| +2% | +$21.9K | 0.25% | 95 |
|
|
2015
Q2 | $957K | Hold |
18,388
| – | – | 0.23% | 101 |
|
|
2015
Q1 | $1.06M | Buy |
18,388
+384
| +2% | +$22.2K | 0.24% | 96 |
|
|
2014
Q4 | $962K | Buy |
18,004
+168
| +0.9% | +$8.98K | 0.22% | 99 |
|
|
2014
Q3 | $1.03M | Hold |
17,836
| – | – | 0.24% | 94 |
|
|
2014
Q2 | $1.19M | Buy |
17,836
+396
| +2% | +$26.5K | 0.27% | 93 |
|
|
2014
Q1 | $1.17M | Sell |
17,440
-348
| -2% | -$23.2K | 0.28% | 90 |
|
|
2013
Q4 | $1.19M | Buy |
17,788
+2,100
| +13% | +$140K | 0.28% | 89 |
|
|
2013
Q3 | $984K | Buy |
15,688
+72
| +0.5% | +$4.52K | 0.26% | 90 |
|
|
2013
Q2 | $975K | Buy |
+15,616
| New | +$975K | 0.27% | 88 |
|